Microscopic spheres of calcium phosphate have been linked to the
development of age-related macular degeneration (AMD), a major
cause of blindness, by UCL-led research.
AMD affects 1 in 5 people over 75, causing their vision to
slowly deteriorate, but the cause of the most common form of the
disease remains a mystery. The ability to spot the disease early
and reliably halt its progression would improve the lives of
millions, but this is simply not possible with current knowledge
and techniques.
The latest research has implicated tiny spheres of mineralised
calcium phosphate, 'hydroxylapatite', in AMD progression. This not
only offers a possible explanation for how AMD develops, but also
opens up new ways to diagnose and treat the disease.
AMD is characterised by a build-up of mainly protein and fat
containing deposits called 'drusen' in the retina, which can
prevent essential nutrients from reaching the eye's light-sensitive
cells, 'photoreceptors'. Photoreceptors are regularly recycled by
cellular processes, creating waste products, but drusen can trap
this 'junk' inside the retina, worsening the build-up. Until now,
nobody understood how drusen formed and grew to clinically relevant
size.
The new study shows that tiny calcium-based hydroxyapatite,
commonly found in bones and teeth, could explain the origin of
drusen. The researchers believe that these spheres attract proteins
and fats to their surface, which build up over years to form
drusen. Through post-mortem examination of 30 eyes from donors
between 43 and 96 years old, the researchers used fluorescent dyes
to identify the tiny spheres, just a few microns - thousandths of a
millimetre - across.
"We found these miniscule hollow spheres inside all of the eyes
and all the deposits that we examined, from donors with and without
AMD," explains Dr Imre Lengyel of the UCL Institute of
Ophthalmology and Moorfields Eye Hospital. "Eyes with more of these
spheres contained more drusen. The spheres appear long before
drusen become visible on clinical examination.
"The fluorescent labelling technique that we used can identify
the early signs of drusen build-up long before they become visible
with current methods. The dyes that we used should be compatible
with existing diagnostic machines. If we could develop a safe way
of getting these dyes into the eye, we could advance AMD diagnoses
by a decade or more and could follow early progression more
precisely."
Some of the mineral spheres identified in the eye samples were
coated with amyloid beta, which is linked to Alzheimer's disease.
If a technique were developed to identify these spheres for AMD
diagnosis, it may also aid early diagnosis of Alzheimer's. Whether
these spheres are a cause or symptom of AMD is still unclear, but
their diagnostic value is significant either way. As drusen are
hallmarks of AMD, then strategies to prevent build-up could
potentially stop AMD from developing altogether.
"The calcium-based spheres are made up of the same compound that
gives teeth and bone their strength, so removal may not be an
option," said Dr Lengyel. "However, if we could get to the spheres
before the fat and protein build-up, we could prevent further
growth. This can already be done in the lab, but much more work is
needed before this could be translated into patients."
"Our discovery opens up an exciting new avenue of scientific
research into potential new diagnostics and treatments, but this is
only the beginning of a long road." said Dr Richard Thompson of the
University of Maryland School of Medicine, USA.
The paper, Identification
of hydroxyapatite spherules provides new insight into subretinal
pigment epithelial deposit formation in the aging eye, is
published in Proceedings of the National Academy of
Sciences.